March 15, 2024 · Form 4 insider transaction
Valencia Catalina bought 7,837,500 shares of AXIM Biotechnologies, Inc. at $156750.00 per share, a transaction worth $1228.53B. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Reporting Person acquired a convertible note, face value $156,750. The note is convertible into shares of the Issuer's common stock at a price of $0.02 per share for conversion into a total of 7,837,500 shares..